Life ScienceCompany
Teva Pharmaceutical Industries has acquired 23 companies. A total of 3 acquisitions came from private equity firms. It has also divested 9 assets.
Teva Pharmaceutical Industries’ largest acquisition to date was in 2015, when it acquired Allergan Generics for $40.5B. It’s largest disclosed sale occurred in 2017, when it sold Teva Pharmaceutical Industries - PARAGARD to CooperSurgical for $1.1B. Teva Pharmaceutical Industries has acquired in 7 different US states, and 8 countries. The Company’s most targeted sectors include life science (87%) and distribution (5%).
Join Mergr and gain access to Teva Pharmaceutical Industries’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity32
- M&A Buy Activity23
- M&A Sell Activity9
- Total Sectors Invested 4
- Total Countries Invested 8
- M&A Buy/Sell Connections 14
- M&A Advisors 12
Unlimited Searches
